Bioanalytical Assays for Oligonucleotide Therapeutics
February 26, 2025
February 26, 2025
NEW ROCHELLE, New York, Feb. 26 -- Mary Ann Liebert Inc. issued the following news release:
* * *
Bioanalytical Assays for Oligonucleotide Therapeutics
New Rochelle, NY, February 25, 2025--A new article in the peer-reviewed journal Nucleic Acid Therapeutics addresses the recognition by the U.S. Food and Drug Administration that immunogenicity assays may be necessary to measure immune responses to different components of oligonucleotide therapeutic (ONT) dru . . .
* * *
Bioanalytical Assays for Oligonucleotide Therapeutics
New Rochelle, NY, February 25, 2025--A new article in the peer-reviewed journal Nucleic Acid Therapeutics addresses the recognition by the U.S. Food and Drug Administration that immunogenicity assays may be necessary to measure immune responses to different components of oligonucleotide therapeutic (ONT) dru . . .